Drug Discovery & Development |
Cancer Research UK to Repurpose AstraZeneca Asthma Drug for Kidney Cancer
Genetic Engineering News AZD2098 was originally designed to treat asthma. CRUK says this deal with AZ will enable its Drug Development Office (DDO) to complete preclinical development and carry out early clinical trials of the compound to see if it can benefit kidney cancer … Cancer Research UK, AstraZeneca To Repurpose Asthma Drug for Kidney Cancer |
View full post on asthma – Google News